← Back to Search

Behavioral Intervention

Resilience Training for Mood Disorders

N/A
Recruiting
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before the intervention, 6 weeks later, and 6 months later
Awards & highlights

Study Summary

This trial aimed to see if teaching resilience skills using virtual reality technology is practical and well-received by participants.

Who is the study for?
The ROOM trial is for college students aged 18-30 enrolled in undergraduate programs and healthcare providers over 18 who work with patients. Participants must speak English well and not be in frequent psychotherapy. Those with acute psychiatric symptoms, current suicidality, or serious substance issues cannot join.Check my eligibility
What is being tested?
This study tests the effectiveness of Resilience Training delivered through virtual reality to help individuals cope better with stressors related to psychosis, anxiety, and mood disorders.See study design
What are the potential side effects?
Since this trial involves psychological resilience training rather than medication, traditional side effects are not expected; however, participants may experience discomfort or emotional distress during the process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before the intervention, 6 weeks later, and 6 months later
This trial's timeline: 3 weeks for screening, Varies for treatment, and before the intervention, 6 weeks later, and 6 months later for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Discomfort with Others
Intervention Feasibility and Acceptability
Penn Emotion Recognition Test
+1 more
Secondary outcome measures
Beck Depression Inventory
Connor-Davidson Resilience Scale
Prodromal Questionnaire- Brief
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Resilience TrainingExperimental Treatment1 Intervention
A 6 1-hour session group based intervention to deliver mindfulness, metallization, and self-compassion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resilience Training
2018
N/A
~110

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,936 Previous Clinical Trials
13,198,547 Total Patients Enrolled
12 Trials studying Mood Disorders
7,270 Patients Enrolled for Mood Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently enrolling participants for this study?

"As per the information on clinicaltrials.gov, this research is actively seeking participants. The study was first listed on September 15th, 2020, and last revised on April 10th, 2024."

Answered by AI

What specific objectives does this medical study aim to fulfill?

"The primary aim of this clinical investigation, which will be assessed at three time points - before the intervention, 6 weeks post-intervention, and 6 months post-intervention - is to assess the Stop Distance Paradigm. Secondary endpoints encompass the Beck Depression Inventory (BDI), a tool comprising 21 self-reported items evaluating depression severity on a scale from 0-63; the Prodromal Questionnaire-Brief (PQ-B), consisting of 21 inquiries measuring psychotic episodes and distress experienced with scores ranging between 0 and 105; as well as the Spielberger State-Trait Anxiety Inventory (STAI), featuring a set"

Answered by AI
~27 spots leftby Jan 2025